KITE PHARMA, INC.

SANTA MONICA, CA How do I update this listing?

Kite Pharma is based out of Santa Monica. Kite Pharma, Inc. develops and manufacturers pharmaceuticals. The company offers and designs cancer immunotherapeutic products and therapy designed to restoring the patient's immune system to recognize and eradicate tumors.Whalewisdom has at least 215 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2014-05-02. The notice included securities offered of Debt

Create Alert

Contact Info

kite pharma, inc.
2225 COLORADO AVENUE
SANTA MONICA CA    90404

Business Phone: (310) 824-9999
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2014-05-02 D BIOTECHNOLOGY Debt 50,000,000 50,000,000 0
2013-05-24 D BIOTECHNOLOGY Equity 16,420,598 16,420,598 0
2012-12-14 D BIOTECHNOLOGY Equity,Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 250,000 250,000 0
2011-03-09 D BIOTECHNOLOGY Equity,Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 12,522,570 12,453,375 69,195
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARIE S. BELLDEGRUN subscription required
    DIRECTOR
AYA JAKOBOVITS subscription required
    EXECUTIVE OFFICER DIRECTOR
CYNTHIA M. BUTITTA subscription required
    EXECUTIVE OFFICER
DAVID BONDERMAN subscription required
    DIRECTOR
FARAH CHAMPSI subscription required
    DIRECTOR
GLORIA LEE subscription required
    EXECUTIVE OFFICER
JONATHAN M. PEACOCK subscription required
    DIRECTOR
JOSHUA A. KAZAM subscription required
    DIRECTOR
KEITH NOLOP subscription required
    EXECUTIVE OFFICER
MARC BETTER subscription required
    EXECUTIVE OFFICER
MARGO R. ROBERTS subscription required
    EXECUTIVE OFFICER
RAN NUSSBAUM subscription required
    DIRECTOR
RIZWANA SPROULE subscription required
    EXECUTIVE OFFICER
ROY DOUMANI subscription required
    DIRECTOR
STEVEN B. RUCHEFSKY subscription required
    DIRECTOR

Elevate your investments